CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,096,663 | +104.2% | 36,875 | +23.5% | 0.00% | +100.0% |
Q2 2023 | $536,976 | +11.0% | 29,854 | -0.9% | 0.00% | 0.0% |
Q1 2023 | $483,566 | +4.6% | 30,110 | +19.2% | 0.00% | 0.0% |
Q4 2022 | $462,423 | +0.5% | 25,269 | +7.8% | 0.00% | 0.0% |
Q3 2022 | $460,000 | +62.0% | 23,436 | +53.5% | 0.00% | 0.0% |
Q2 2022 | $284,000 | – | 15,269 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |